Evidence map›Paper›PMID 32853139›Full record

ArticleJournal of hospital medicine2020

Multiplying the Impact of Opioid Settlement Funds by Investing in Primary Prevention.

Laura J Faherty, Scott E Hadland, Bradley D Stein, Stephen W Patrick

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of hospital medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Laura J FahertyRAND Corporation, Boston, Massachusetts.
Scott E HadlandDepartment of Pediatrics, Boston Medical Center, Boston, Massachusetts.
Bradley D SteinRAND Corporation, Pittsburgh, Pennsylvania.
Stephen W PatrickDepartment of Health Policy, Vanderbilt University, Nashville, Tennessee.

Funding

Optimal Methods for Estimating Policy Effect Heterogeneity in Opioid Policy ResearchP50DA046351 · NIDA · RAND CORPORATION · PI BRADLEY D STEIN · 2018 to 2026
$20.8M
Improving Access to Treatment for Women with Opioid Use DisorderR01DA045729 · NIDA · VANDERBILT UNIVERSITY MEDICAL CENTER · PI PATRICK, STEPHEN W · 2018 to 2021
$1.5M
Collaborative Care Office-Based Opioid Treatment for Adolescents and Young AdultsK23DA045085 · NIDA · MASSACHUSETTS GENERAL HOSPITAL · PI HADLAND, SCOTT EVAN · 2018 to 2022
$1.1M
Neonatal Abstinence Syndrome: Risk of Drug Withdrawal in Opioid-Exposed InfantsK23DA038720 · NIDA · VANDERBILT UNIVERSITY MEDICAL CENTER · PI PATRICK, STEPHEN W · 2015 to 2019
$844k
An Exploratory Analysis of the Association of State Policies with Neonatal Abstinence SyndromeR21DA045212 · NIDA · RAND CORPORATION · PI FAHERTY, LAURA JOHNSON · 2018 to 2019
$490k
NIDA NIH HHS K23 DA038720NIDA NIH HHS K23 DA045085NIDA NIH HHS L40 DA042434NIDA NIH HHS P50 DA046351NIDA NIH HHS R01 DA045729NIDA NIH HHS R21 DA045212
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Analgesics, OpioidFinancial ManagementHumansPrimary PreventionAnalgesics, Opioid

Identifiers

PMID32853139
PMCPMC7531941

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.